Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma

By Dunlop William   Heron Louise   Fox Georgia   Greaney Maire  

Advances in Therapy, Vol. 30, Iss. 10, 2013-10 ,pp. : 933-944

Springer Publishing Company

Access to resources Recommend Favorite

Bronchoprotective and Bronchodilator Effects of an HFA pMDI vs. a CFC pMDI and a DPI Containing Formoterol in Asthma Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 35-37

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Efficacy Crossover Trial Comparing Formoterol-HFA (pMDI) versus Formoterol-DPI (Aerolizer^TM) and Placebo (pMDI or Aerolizer^TM) in Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 6-12

Karger

Access to resources Recommend Favorite

Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*

By Tamminen Klaus   Laine Juha   Soini Erkki   Martikainen Janne   Kankaanranta Hannu  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3453-3461

Informa Healthcare

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Crossover Trial Evaluating the Efficacy and Safety Profiles of Two Dose Levels (12 and 24 μg) of Formoterol-HFA (pMDI) vs. Those of a Dose Level (24 μg) of Formoterol-DPI (Foradil^®/Aerolizer^™) and of Placebo (pMDI or Aerolizer) in Moderate to Severe Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 13-19

Karger

Access to resources Recommend Favorite